CD8A and type 1 diabetes mellitus: Alefacept preserves endogenous insulin C-peptide production of T1D patients to a certain extent, which is related to hypo proliferative CD8 memory cells expressing exhaustion-associated markers including TIGIT and KLRG1 (121).